Five things to know:
1. Fourth-quarter net loss decreased from $9.5 million to $8.6 million, representing a 9.5 percent decrease year-over-year.
2. SeaSpine reported $159.1 million in full-year 2019 revenue, which is an 11 percent increase compared to 2018.
3. U.S. revenue increased 16 percent year-over-year to $39.3 million.
4. Domestic spinal implants revenue consisted of $19.1 million of U.S. revenue, which increased 21 percent year-over-year.
5. Domestic orthobiologics revenue increased 11 percent to $20.2 million, representing an 11 percent increase year-over-year.
More articles on devices:
Zimmer Biomet cervical disc surpasses 150,000 implants
Orthofix’s positive Q4 can’t eclipse $28M 2019 loss
SASpine partners with Dr. Stanley Jones, establishes new location
